ArticleF&S reports2021

Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis.

Ozgul Muneyyirci-Delale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.